Results 121 to 130 of about 12,456 (182)

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes. [PDF]

J Clin Psychiatry
Votaw VR, Bailey AJ, Weiss RD, McHugh RK.   +3 more
europepmc   +1 more source

State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients.

JAMA Health Forum
Hu JC, Kapadia SN, Zhang H, Jalali A, Underhill K, Andrews CM, Bao Y.   +6 more
europepmc   +1 more source

Studies of the mechanism of antidiuretic hormone release [PDF]

, 1977
Dahl, G., Gratzl, Manfred, Moses, A. M., Russell, J. T., Thorn, N. A.   +4 more
core  

Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment: protocol for a scoping review. [PDF]

BMJ Open
Henderson C, Walker S, Lloyd Z, Gibbs D, Romero L, Stoové MA.   +5 more
europepmc   +1 more source

Implementation of low-dose buprenorphine induction at a syringe services program. [PDF]

Addict Sci Clin Pract
Hauschild MH, Warp PV, Eger WH, Hood R, Bahamon M, Forrest DW, Bartholomew TS, Suarez E, Chueng TA, Ciraldo KJ, Tookes HE, Serota DP.   +11 more
europepmc   +1 more source

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

Health Technol Assess
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, Evans BA, Fuller G, Hoskins R, Hughes J, Jones J, Jones M, Johnston S, Long J, Moore C, Parab R, Pilbery R, Sampson FC, Watkins A.   +18 more
europepmc   +1 more source

Over-the-counter naloxone sales and pricing variability in North Carolina following FDA approval. [PDF]

J Subst Use Addict Treat
Johnson JM, Annis IE, Delamater P, Marley GT, Hincapie-Castillo JM, Carpenter DM.   +5 more
europepmc   +1 more source

Book Reviews [PDF]

, 1972

core   +1 more source

Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial. [PDF]

United European Gastroenterol J
Cook ME, Knoph CS, Davidsen L, Frøkjær JB, Bruun NH, Novovic S, Hadi A, Jørgensen MT, Mortensen MB, Schaffalitzky O, Nielsen LBJ, Berner-Hansen M, Drewes AM, Olesen SS.   +13 more
europepmc   +1 more source

Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. [PDF]

Pharmacoepidemiol Drug Saf
Ross RK, Butler AM, Seamans MJ, Williams AR, Samples H, Rudolph KE.   +5 more
europepmc   +1 more source